肝细胞条件性Eva1a/Tmem166基因敲除小鼠的表型分析

doi:10.3969/j.issn.1006-7795.2021.04.010

首都医科大学学报 ›› 2021, Vol. 42 ›› Issue (4): 568-574.doi: 10.3969/j.issn.1006-7795.2021.04.010

肝细胞条件性Eva1a/Tmem166基因敲除小鼠的表型分析

陈建宏¹, 林欣², 冯金秋², 丁鹏鹏¹, 王苗苗¹, 林琳¹, 刘红^1*, 吴静^3*

1.首都医科大学附属北京世纪坛医院消化内科,北京 100038;
2.北京大学人类疾病基因研究中心,北京 100083;
3.首都医科大学附属北京友谊医院消化内科国家消化系统疾病临床医学研究中心北京市消化疾病中心消化疾病癌前病变北京市重点实验室,北京 100050

收稿日期:2020-12-01 出版日期:2021-08-21 发布日期:2021-07-29
基金资助:
国家自然科学基金(81900505),北京市医院管理中心“青苗”计划资助项目(QML20200702),北京世纪坛医院青年基金(2018-q09)。

Phenotypic analysis of hepatocyte-specific Eva1a/Tmem166 gene knockout mice

Chen Jianhong¹, Lin Xin², Feng Jinqiu², Ding Pengpeng¹, Wang Miaomiao¹, Lin Lin¹, Liu Hong^1*, Wu Jing^3*

1. Department of Gastroenterology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China;
2. Peking University Center for Human Diseases Genomics, Beijing 100083, China;
3. Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Diseases, Beijing Digestive Disease Center, Beijing Key Laboratory for Precancerous Lesion of Digestive Diseases, Beijing 100050, China

Received:2020-12-01 Online:2021-08-21 Published:2021-07-29
Contact: * E-mail:wujing36youyi@ccmu.edu.cn; liuhong_sjt@ccmu.edu.cn
Supported by:
National Natural Science Foundation of China (81900505), Beijing Municipal Administration of Hospitals' Youth Programe (QML20200702), Youth Fund of Beijing Shijitan Hospital (2018-q09).

摘要/Abstract

摘要： 目的应用Cre-LoxP技术构建自噬相关基因Eva1a肝细胞条件性敲除小鼠初步探讨Eva1a基因敲除对小鼠表型的影响。方法 LoxP标记的Eva1a^flox/+小鼠与Alb-Cre工具鼠通过多次繁殖杂交,构建纯合型肝细胞条件性Eva1a基因敲除(Eva1a^flox/flox: Alb-Cre)小鼠模型。选取Eva1a^flox/flox: Alb-Cre小鼠与同窝野生(Eva1a^flox/flox)小鼠雌雄进行体质量、肝指数、肝脏组织学、肝功能、糖脂代谢以及细胞自噬等表型分析。结果 Eva1a纯合型基因敲除小鼠无胚胎致死现象,出生后一般生理状况良好。常规饲养条件下,肝脏Eva1a基因条件性敲除在小鼠体质量、肝脏外观以及组织结构、肝指数、肝功能、糖脂代谢及自噬等与野生型小鼠差异无统计学意义。结论肝细胞条件性Eva1a基因敲除对小鼠生理条件下的表型无显著影响,为进一步探讨Eva1a在肝脏疾病状态下的作用及分子机制提供了动物模型。

关键词: Eva1a/Tmem166, 基因敲除, 肝脏, 表型

Abstract: Objective To construct mice models with hepatocyte-specific knockout of autophagy related gene Eva1a using Cre-LoxP technique, and to preliminarily explore the effect of Eva1a gene knockout on the phenotype of mice. Methods LoxP-labeled Eva1a^flox/+ mice and Alb-Cre mice were used to construct homozygous mice models with hepatocyte-specific Eva1a gene knockout (Eva1a^flox/flox: Alb-Cre) through multiple generations of hybridization. Eva1a^flox/flox: Alb-Cre mice and Eva1aflox/flox mice were selected for phenotypic analysis, including body mass, liver index, liver histology, liver function, glycolipid metabolism, and autophagy level. Results There was no fetal death in homozygous Eva1a knockout mice, and no significant changes in the physiological condition were found. In conventional feeding conditions, hepatocyte-specific Eva1a knockout had no significant difference in body weight, liver appearance, tissue structure, liver index, liver function, glucose and lipid metabolism, and autophagy level from wild-type mice. Conclusion Hepatocyte-specific Eva1a gene knockout had no significant effect on the phenotype of mice in the physiological condition, and our study provided an animal model to further explore the role and molecular mechanism of Eva1a in liver disease.

Key words: Eva1a/Tmem166, gene knockout, liver, phenotype

中图分类号:

R575

陈建宏, 林欣, 冯金秋, 丁鹏鹏, 王苗苗, 林琳, 刘红, 吴静. 肝细胞条件性Eva1a/Tmem166基因敲除小鼠的表型分析[J]. 首都医科大学学报, 2021, 42(4): 568-574.

Chen Jianhong, Lin Xin, Feng Jinqiu, Ding Pengpeng, Wang Miaomiao, Lin Lin, Liu Hong, Wu Jing. Phenotypic analysis of hepatocyte-specific Eva1a/Tmem166 gene knockout mice[J]. Journal of Capital Medical University, 2021, 42(4): 568-574.

参考文献

[1] Ryter S W, Bhatia D, Choi M E. Autophagy: a lysosome-dependent process with implications in cellular redox homeostasis and human disease[J]. Antioxid Redox Signal, 2019, 30(1): 138-159.
[2] Cheng Z Y. The Fox O-autophagy axis in health and disease[J]. Trends Endocrinol Metab, 2019, 30(9): 658-671.
[3] Ueno T, Komatsu M. Autophagy in the liver: functions in health and disease[J].Nat Rev Gastroenterol Hepatol, 2017, 14(3): 170-184.
[4] 李相迁,王玮,贾艳红,等. 细胞自噬与非乙醇性脂肪性肝病[J].中华肝脏病杂志, 2016, 8(24): 632-635.
[5] Wang L, Yu C F, Lu Y, et al. TMEM166, a novel transmembrane protein, regulates cell autophagy and apoptosis[J]. Apoptosis, 2007, 12(8): 1489-1502.
[6] Xu D, Yang F, He H, et al. Expression of TMEM166 protein in human normal and tumor tissues[J]. Appl Immunohistochem Mol Morphol, 2013, 21(6): 543-552.
[7] Chang Y, Li Y J, Hu J, et al. Adenovirus vector-mediated expression of TMEM166 inhibits human cancer cell growth by autophagy and apoptosis in vitro and in vivo[J].Cancer Lett, 2013, 328(1): 126-134.
[8] Hu J, Li G, Qu L J, et al. TMEM166/ EVA1A interacts with ATG16L1 and induces autophagosome formation and cell death[J]. Cell Death Dis, 2016, 7(8): e2323.
[9] Li M T, Lu G, Hu J, et al. EVA1A/TMEM166 regulates embryonic neurogenesis by autophagy[J].Stem Cell Reports, 2016, 6(3): 396-410.
[10] Zhang S, Lin X, Li G, et al. Knockout of Eva1a leads to rapid development of heart failure by impairing autophagy[J]. Cell Death Dis, 2017, 8(2): e2586.
[11] Lu G D, Yang H A, Zhou J, et al. CCAAT/enhancer binding protein alpha predicts poorer prognosis and prevents energy starvation-induced cell death in hepatocellular carcinoma[J]. Hepatology, 2015, 61(3): 965-978.
[12] Ren W W, Li D D, Chen X, et al. MicroRNA-125b reverses oxaliplatin resistance in hepatocellular carcinoma by negatively regulating EVA1A mediated autophagy[J].Cell Death Dis, 2018, 9(5): 547.
[13] Lin X, Cui M, Xu D, et al. Liver-specific deletion of Eva1a/Tmem166 aggravates acute liver injury by impairing autophagy[J]. Cell Death Dis,2018, 9 (7): 768.
[14] Takamura A, Komatsu M, Hara T, et al. Autophagy-deficient mice develop multiple liver tumors[J]. Genes Dev, 2011, 25(8): 795-800.
[15] Zhao Y W, Wang Q Y, Qiu G H, et al. RACK1 promotes Autophagy by enhancing the Atg14L-Beclin 1-Vps34- Vps15 complex formation upon phosphorylation by AMPK[J]. Cell Rep, 2015, 13(7): 1407-1417.
[16] Martinez-Lopez N, Singh R. Autophagy and lipid droplets in the liver[J]. Annu Rev Nutr, 2015, 35: 215-237.
[17] 中华医学会肝病学分会脂肪肝和乙醇性肝病学组, 中国医师协会脂肪性肝病专家委员会. 非乙醇性脂肪性肝病防治指南(2018更新版) [J]. 中华肝脏病杂志, 2018, 3(26): 195-203.
[18] 武楠,王晓晓,费然,等.幼鼠非酒精性脂肪性肝炎模型的建立及其肝纤维化特征的研究[J].中国医科大学学报,2020,49(3):209-214.

肝细胞条件性Eva1a/Tmem166基因敲除小鼠的表型分析

Phenotypic analysis of hepatocyte-specific Eva1a/Tmem166 gene knockout mice

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	张冬雪, 文祯, 孙玉燕, 姜涛. 初诊2型糖尿病患者中肝脏胰岛素清除率与临床特点及胃肠激素相关性的初步分析[J]. 首都医科大学学报, 2021, 42(5): 822-828.
[2]	柳鑫, 徐有青, 崔纯莹, 赵志刚. GPIHBP1基因敲除小鼠在严重高三酰甘油血症急性胰腺炎导致肺损伤研究中的应用[J]. 首都医科大学学报, 2020, 41(4): 564-569.
[3]	卢晶, 李奇, 朱晓蓉, 谢荣荣, 杨金奎. KCNH6基因肝脏特异性敲除小鼠的构建及其初步应用[J]. 首都医科大学学报, 2020, 41(1): 8-13.
[4]	李奇, 卢晶, 朱晓蓉, 熊枫然, 杨金奎. Unc13基因胰岛β细胞条件性敲除小鼠模型的构建和鉴定[J]. 首都医科大学学报, 2020, 41(1): 14-20.
[5]	张怡尘, 曹曦, 杨金奎. G蛋白偶联受体MAS对肝脏糖脂代谢的影响[J]. 首都医科大学学报, 2019, 40(3): 409-416.
[6]	卢晶, 沈涵, 程呈, 刘敬怡, 朱晓蓉, 谢荣荣, 袁明霞, 杨金奎. 人ether-α-go-go钾通道减少肝脏的内质网应激和凋亡[J]. 首都医科大学学报, 2019, 40(1): 45-52.
[7]	曹曦, 宋丽妮, 张怡尘, 李奇, 杨金奎. 应用CRISPR/Cas9技术制备MrgD基因敲除小鼠模型[J]. 首都医科大学学报, 2018, 39(4): 517-521.
[8]	李东, 张树琛, 时琰丽, 李雪清, 鲁炳怀. 北京地区孕晚期妇女定植B族链球菌耐药状况与血清型分布情况分析[J]. 首都医科大学学报, 2018, 39(4): 591-595.
[9]	蔡晓飞, 牛少宁, 丁乔, 程灏. 不同麻醉药物行全身麻醉复合硬膜外阻滞对肝脏切除术后肝肾功能的影响[J]. 首都医科大学学报, 2017, 38(3): 352-356.
[10]	吕卫华, 王青, 赵清华, 吴薇, 翟雪靓, 张少景, 符琳琳. 住院老年病人营养状况与衰弱相关性研究[J]. 首都医科大学学报, 2017, 38(3): 377-380.
[11]	董常峰, 曾政, 刘映霞, 李汉英, 陈昕, 骆永芳, 单灵波, 黄华, 陆普选. 剪切波速对比磁共振弥散成像评价慢性乙型肝炎肝纤维化程度[J]. 首都医科大学学报, 2016, 37(4): 465-471.
[12]	卢晶, 吴谦, 谢荣荣, 仇海燕, 程呈, 杨金奎. β位淀粉样前体蛋白裂解酶2基因敲除斑马鱼动物模型的构建及其初步应用[J]. 首都医科大学学报, 2015, 36(6): 839-843.
[13]	程呈, 吴谦, 卢晶, 仇海燕, 李倩, 杨金奎. 基于CRISPR/Cas9研究RFX6对斑马鱼胰腺发育的影响[J]. 首都医科大学学报, 2015, 36(6): 844-847.
[14]	王珏, 戴洁, 王大业, 吕福东, 胡子净, 金荣华, 齐晶, 段雪晶. 新型甲型H1N1流感重症病例肝脏病理学变化分析[J]. 首都医科大学学报, 2015, 36(3): 437-440.
[15]	张云巍, 徐丽娟, 王淑芳, 阎丽. 人脂肪间充质干细胞体外诱导为肝脏样细胞的试验研究[J]. 首都医科大学学报, 2014, 35(5): 608-616.